Skip to main content
. Author manuscript; available in PMC: 2019 Jun 19.
Published in final edited form as: Clin Genitourin Cancer. 2016 May 27;15(1):77–85. doi: 10.1016/j.clgc.2016.05.010

Table 2.

Incidence of TRC105-Related Adverse Events (n = 13)

Adverse Event All Grades Grade 1 Grade 2 Grade 3 Grade 4
Anemia   6 (46) 1 (8) 4 (31) 1 (8)
Anorexia 1 (8) 1 (8)
Cough 1 (8) 1 (8)
Edema (Limbs) 1 (8) 1 (8)
Epistaxis   6 (46)   6 (46)
Fatigue 1 (8) 1 (8)
Gum Bleeding   4 (31)   4 (31)
Headache   9 (69)   8 (62) 1 (8)
Hematuria 1 (8) 1 (8) 1 (8)
Hypoalbuminemia 1 (8) 1 (8)
Hypophosphatemia 1 (8) 1 (8)
Increased Alanine Aminotransferase 1 (8) 1 (8)
Infusion-Related
Reaction
  9 (69)   5 (38)   4 (31)
Maculopapular Rash 1 (8) 1 (8)
Nasal Congestion   3 (23)   3 (23)
Nausea 1 (8) 1 (8)
Proteinuria 1 (8) 1 (8)
Skin Infection 1 (8) 1 (8)
Telangiectasia   6 (46)   6 (46)
Vomiting 1 (8) 1 (8)
Xerostomia 1 (8) 1 (8)